Euro
USD
British Pound
NULL
Product Description
This research-grade biosimilar is a monoclonal antibody with a human IgG2A backbone fused to the antigen-binding domain and targets CD20, a surface antigen found on B lymphocytes. Binding of the CD20 surface antigen has been shown to induce apoptosis in B lymphocytes in vitro. The humanized anti-CD20 antibody, in concert with a carrier, acts as a delivery system for radioimmunotherapy against B cell lymphoma.
Biovision | A2291 | Anti-CD20 (Ibritumomab), Humanized Antibody DataSheet
Antibody Target: Human CD20
Target Alternative Name: B1; S7; Bp35; CD20; CVID5; MS4A1; LEU-16
Tag Line: A humanized antibody that binds to CD20
Category: GM-CSF
Host: CHO cells
Isotype: IgG2A
Species Reactivities: Human
Immunogen Sequence: FALSE
Accession #: P11836
Gene ID: 931
Appearance: Liquid
Form: FALSE
Concentration: 1 mg/mL
Formulation: In PBS pH 7.5
Purification: FALSE
Application: FALSE
Positive Control:
Application And Usages:
Country of Animal Origin: USA
Country of Manufacture: USA
Usage: For Research Use Only! Not to be used in humans.
Handling: The antibody solution should be gently mixed before use.
Western Blot Verified: FALSE
Immunocytochemistry Verified:
Immunofluorescence Verified: FALSE
Immunoprecipitation Verified: FALSE
FACS Verified:
ELISA Verified: FALSE
ChIP Verified: FALSE
Dot Blot Verified: FALSE
Flow Cytometry Verified: FALSE
